These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28763528)

  • 41. Recording transcriptional activity.
    Rusk N
    Nat Methods; 2018 Dec; 15(12):999. PubMed ID: 30504868
    [No Abstract]   [Full Text] [Related]  

  • 42. Technique: SNP-CLINGing onto your post in the genome.
    Cloney R
    Nat Rev Genet; 2018 Mar; 19(3):126-127. PubMed ID: 29353874
    [No Abstract]   [Full Text] [Related]  

  • 43. Small science: high stakes.
    Gamazon ER
    Science; 2012 Nov; 338(6109):883. PubMed ID: 23161975
    [No Abstract]   [Full Text] [Related]  

  • 44. Small science: radical innovation.
    Berlekamp E
    Science; 2012 Nov; 338(6109):882. PubMed ID: 23161972
    [No Abstract]   [Full Text] [Related]  

  • 45. Small science: view from developing nations.
    Slippers B
    Science; 2012 Nov; 338(6109):882. PubMed ID: 23161973
    [No Abstract]   [Full Text] [Related]  

  • 46. CRISPRing the Regulatory Genome, the Challenge Ahead.
    Sansbury SE; Sweeney KM; Shalem O
    Trends Genet; 2017 Sep; 33(9):580-582. PubMed ID: 28764860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries.
    Ong SH; Li Y; Koike-Yusa H; Yusa K
    Sci Rep; 2017 Aug; 7(1):7384. PubMed ID: 28785007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of essential genes for cancer immunotherapy.
    Patel SJ; Sanjana NE; Kishton RJ; Eidizadeh A; Vodnala SK; Cam M; Gartner JJ; Jia L; Steinberg SM; Yamamoto TN; Merchant AS; Mehta GU; Chichura A; Shalem O; Tran E; Eil R; Sukumar M; Guijarro EP; Day CP; Robbins P; Feldman S; Merlino G; Zhang F; Restifo NP
    Nature; 2017 Aug; 548(7669):537-542. PubMed ID: 28783722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPRpred: A flexible and efficient tool for sgRNAs on-target activity prediction in CRISPR/Cas9 systems.
    Rahman MK; Rahman MS
    PLoS One; 2017; 12(8):e0181943. PubMed ID: 28767689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epigenome editors: How tools such as CRISPR offer new details about epigenetics.
    Willyard C
    Nat Med; 2017 Aug; 23(8):900-903. PubMed ID: 28777784
    [No Abstract]   [Full Text] [Related]  

  • 51. Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells.
    Li G; Zhang X; Zhong C; Mo J; Quan R; Yang J; Liu D; Li Z; Yang H; Wu Z
    Sci Rep; 2017 Aug; 7(1):8943. PubMed ID: 28827551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome editing: CRISPR-Cas becoming more human.
    Baumann K
    Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
    [No Abstract]   [Full Text] [Related]  

  • 53. AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.
    Chow RD; Guzman CD; Wang G; Schmidt F; Youngblood MW; Ye L; Errami Y; Dong MB; Martinez MA; Zhang S; Renauer P; Bilguvar K; Gunel M; Sharp PA; Zhang F; Platt RJ; Chen S
    Nat Neurosci; 2017 Oct; 20(10):1329-1341. PubMed ID: 28805815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-Wide CRISPR/Cas9 Screening for High-Throughput Functional Genomics in Human Cells.
    Zhu S; Zhou Y; Wei W
    Methods Mol Biol; 2017; 1656():175-181. PubMed ID: 28808970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood.
    Joung J; Engreitz JM; Konermann S; Abudayyeh OO; Verdine VK; Aguet F; Gootenberg JS; Sanjana NE; Wright JB; Fulco CP; Tseng YY; Yoon CH; Boehm JS; Lander ES; Zhang F
    Nature; 2017 Aug; 548(7667):343-346. PubMed ID: 28792927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracellular signaling in CRISPR-Cas defense.
    Amitai G; Sorek R
    Science; 2017 Aug; 357(6351):550-551. PubMed ID: 28798118
    [No Abstract]   [Full Text] [Related]  

  • 57. Advances in Industrial Biotechnology Using CRISPR-Cas Systems.
    Donohoue PD; Barrangou R; May AP
    Trends Biotechnol; 2018 Feb; 36(2):134-146. PubMed ID: 28778606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Reverse Transcriptases Associated with CRISPR-Cas Systems.
    Toro N; Martínez-Abarca F; González-Delgado A
    Sci Rep; 2017 Aug; 7(1):7089. PubMed ID: 28769116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells.
    Voets O; Tielen F; Elstak E; Benschop J; Grimbergen M; Stallen J; Janssen R; van Marle A; Essrich C
    PLoS One; 2017; 12(8):e0182974. PubMed ID: 28800587
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.